These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18519951)

  • 1. Lung cancer staging techniques and induction therapy: maybe timing is everything.
    Pass HI
    J Clin Oncol; 2008 Jul; 26(20):3306-7. PubMed ID: 18519951
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 3. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
    Van Schil PE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining prognosis in non-small-cell lung cancer.
    Singh T; Dhindsa J
    N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathologic complete responses after chemotherapy plus figitumumab in stage IV non-small-cell lung cancer.
    Corral J; López-Villalobos JL; Gomez-Izquierdo L; Borrego I; Paz-Ares L
    J Clin Oncol; 2011 Mar; 29(7):e163-5. PubMed ID: 21149666
    [No Abstract]   [Full Text] [Related]  

  • 10. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchial carcinoma--percutaneous needle biopsy does not led to mortality].
    Fath R
    Pneumologie; 2007 Sep; 61(9):558. PubMed ID: 17939082
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Paleari L; Russo P; Cesario A; Granone P
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of elderly patients with stage IV non-small-cell lung cancer.
    Weiss J; Stinchcombe TE
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):111-20. PubMed ID: 22149437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary.
    Goldberg M
    Ann Thorac Surg; 2006 Jan; 81(1):304. PubMed ID: 16368386
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative data from lung cancer trial may change practice guidelines, study designs.
    McNeil C
    J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of advanced non-small cell lung neoplasms: a closed debate?].
    Le Guen Y; Soria JC; Ruffié P
    Bull Cancer; 2003 Mar; 90(3):199-201. PubMed ID: 12801821
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
    Bearz A; Serraino D; Fratino L; Berretta M; Tirelli U
    Cancer; 2007 Dec; 110(11):2593-4; author reply 2594. PubMed ID: 17960771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of non-small-cell lung carcinoma: PS2 patients' particularities].
    Deppermann KM
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S31-4S34. PubMed ID: 15687991
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preoperative chemotherapy for lung cancer].
    Suzuki K
    Nihon Rinsho; 2002 May; 60 Suppl 5():438-41. PubMed ID: 12101709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.